I 
111TH CONGRESS 
2D SESSION 
H. R. 5354 
To establish an Advisory Committee on Gestational Diabetes, to provide 
grants to better understand and reduce gestational diabetes, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 20, 2010 
Mr. ENGEL (for himself, Mr. BURGESS, Ms. DEGETTE, Mr. CASTLE, Mr. 
GENE GREEN of Texas, Mr. KING of New York, Mrs. CAPPS, Mr. GON-
ZALEZ, Ms. BALDWIN, Mr. RANGEL, Mr. HIGGINS, Mrs. MALONEY, Mr. 
ACKERMAN, Ms. CLARKE, Ms. LEE of California, Mr. SERRANO, and Mr. 
DOYLE) introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce 
A BILL 
To establish an Advisory Committee on Gestational Diabetes, 
to provide grants to better understand and reduce gesta-
tional diabetes, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Gestational Diabetes 
Act of 2009’’ or the ‘‘GEDI Act’’. 
SEC. 2. FINDINGS. 
The Congress finds the following: 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
(1) The prevalence of gestational diabetes 
among pregnant women in the United States is in-
creasing. 
(2) Gestational diabetes, which is similar to 
chronic forms of diabetes, normally appears at 24 to 
28 weeks gestation and occurs in approximately 4 to 
8 percent of pregnant women. 
(3) The associated risk factors for gestational 
diabetes include overweight, obesity, lack of physical 
activity, genetics, ethnicity, and age. 
(4) There is disagreement among physicians 
about how to treat gestational diabetes, as well as 
the effectiveness of current treatment regimens. 
(5) Gestational diabetes, which increases the 
risk of preeclampsia, also increases a pregnant wom-
an’s risk for developing gestational diabetes in sub-
sequent pregnancies. 
(6) Infants of women who develop gestational 
diabetes may have extreme increases in birth weight 
and the risks related to difficulties during the birth-
ing process, and infants born to these women— 
(A) may subsequently have low blood sugar 
or jaundice during the newborn period; 
(B) are at increased risk for birth trauma; 
and 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
(C) may be at increased risk of developing 
type 2 diabetes and obesity as an adolescent or 
adult. 
(7) Improved nutrition and increased physical 
activity before, during, and after pregnancy may sig-
nificantly decrease the rates of gestational diabetes 
and its recurrence. 
(8) Obese pregnant women have a three-fold 
risk for the development of gestational diabetes as 
compared with normal weight women. 
SEC. 3. GESTATIONAL DIABETES. 
The Public Health Service Act (42 U.S.C. 201 et 
seq.) is amended by adding at the end the following: 
‘‘TITLE XXXIII—GESTATIONAL 
DIABETES 
‘‘SEC. 3301. UNDERSTANDING AND MONITORING GESTA-
TIONAL DIABETES DURING PREGNANCY. 
‘‘(a) IN GENERAL.—The Secretary of Health and 
Human Services, acting through the Director of the Cen-
ters for Disease Control and Prevention, shall convene a 
Research Advisory Committee. 
‘‘(b) MEMBERSHIP.—The members of the Research 
Advisory Committee— 
‘‘(1) shall include— 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
‘‘(A) a representative from the Agency for 
Healthcare Research and Quality; 
‘‘(B) a representative from the Centers for 
Disease Control and Prevention; 
‘‘(C) a representative from the National 
Institutes of Health; 
‘‘(D) a representative from the Office of 
Minority Health; 
‘‘(E) a representative from the Indian 
Health Service; 
‘‘(F) a representative from the National 
Center for Health Statistics; and 
‘‘(G) representatives from other appro-
priate Federal agencies; and 
‘‘(2) may include representatives from other ap-
propriate organizations. 
‘‘(c) MATTERS TO BE STUDIED.—The Director of 
the Centers for Disease Control and Prevention, in con-
sultation with the Research Advisory Committee, shall de-
velop a multisite, gestational diabetes research project 
within the diabetes program of the Centers for Disease 
Control and Prevention to expand and enhance surveil-
lance data and public health research on gestational diabe-
tes. The project shall address— 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS